Outcome of Targeted Therapy Recommendations for Metastatic and Recurrent Head and Neck Cancers

SIMPLE SUMMARY: In this retrospective study, we aimed to provide molecular-driven therapy recommendations for patients with recurrent/metastatic head and neck cancers based on the respective individual molecular profile. For 31 of 50 patients (62.0% of all patients), a targeted therapy approach coul...

Descripción completa

Detalles Bibliográficos
Autores principales: Taghizadeh, Hossein, Mader, Robert M., Müllauer, Leonhard, Fuereder, Thorsten, Kautzky-Willer, Alexandra, Prager, Gerald W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696688/
https://www.ncbi.nlm.nih.gov/pubmed/33203166
http://dx.doi.org/10.3390/cancers12113381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696688/
https://www.ncbi.nlm.nih.gov/pubmed/33203166
http://dx.doi.org/10.3390/cancers12113381

Ejemplares similares